Allianz Asset Management
CLBT icon

Allianz Asset Management’s Cellebrite CLBT Stock Holding History

Allianz Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-382,376
Closed -$5.27M – 2156
2026
Q1 		$5.27M Buy
+382,376
New +$5.76M 0.01% 1139
2025
Q3 		– Sell
-18,521
Closed -$296K – 2012
2025
Q2 		$296K Sell
18,521
-5,984
-24% -$107K ﹤0.01% 1907
2025
Q1 		$476K Buy
+24,505
New +$516K ﹤0.01% 1892

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Allianz Asset Management's CLBT Position: Q2 2026 in Review

Allianz Asset Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 382,376 shares — an estimated $5.27M sold.

Allianz Asset Management first reported a position in CLBT in Q1 2025 and held it in 3 quarters. The position peaked at $5.27M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Allianz Asset Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Allianz Asset Management sold 382,376 Cellebrite shares in Q2 2026, an estimated $5.27M.
  • Allianz Asset Management first reported a position in Cellebrite in Q1 2025 and held it in 3 quarters.
  • Allianz Asset Management's Cellebrite position peaked at $5.27M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.